Dengue Vaccine Hesitancy Among International Travelers
NCT06418854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 390
Last updated 2025-02-20
Summary
The goal of this cross-sectional study is to study dengue vaccine hesitancy among 390 international travelers who visit the Hospital for Tropical Diseases, Bangkok, and three public sites which are the area near the Grand Palace, Khaosan Road, and the snake farm at Queen Saovabha Memorial Institute. The main question it aims to answer is what are the factors associated with the dengue vaccine hesitancy among non-endemic international travelers visiting Thailand.
Participants will do the questionnaire consists of three parts
1. Questionnaire to estimate vaccine hesitancy on each 5 domains.
2. Knowledge about dengue infection and vaccination
3. Demographics data of the participants The study prioritizes ethical considerations, confidentiality, and data management to ensure participant welfare and data security.
Conditions
- Vaccine Hesitancy
Interventions
- OTHER
-
Questionnaire
Adapted design questionnaire to estimate the vaccine hesitancy specifically for dengue vaccine
Sponsors & Collaborators
-
Mahidol University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-06-01
- Primary Completion
- 2024-11-01
- Completion
- 2024-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
Characterisation of Dengue Vaccine-induced Specific Immunity in Vaccinees With and Without Prior Exposure to Flavivirus Infections or Vaccination
NCT06776692 ·Status: RECRUITING
-
Safety Study of Dengushield in Healthy Adults
NCT03883620 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating Vector-Borne Determinants of Aedes Transmitted Arboviral Infections in Cambodia: An Observational Longitudinal Cohort Study in Children
NCT03534245 ·Status: COMPLETED
-
Clinical Bridging Study Between V181 (Dengue Quadrivalent Vaccine rDENVΔ30 [Live, Attenuated]) to Butantan Dengue Vaccine (Butantan - DV) in Healthy Adults 18 to 50 Years of Age in Brazil (V181 - 002)
NCT05710224 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of the Malaria Vaccine, R21/MatrixM, in Healthy Thai Adults
NCT05252845 ·Status: COMPLETED ·Phase: PHASE2
-
Detection of Dengue Virus in Plasma of Patients in Nepal
NCT03620487 ·Status: COMPLETED
-
Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)
NCT02555072 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Experimental Vaccine for Malaria in Adults in Mali
NCT00343005 ·Status: COMPLETED ·Phase: PHASE1
-
Applying Wolbachia to Eliminate Dengue
NCT03055585 ·Status: TERMINATED ·Phase: NA
-
Duration of Immunity 10 Years After a Dose-response Study With Yellow Fever Vaccine - Complementary Study
NCT04416477 ·Status: UNKNOWN
-
Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis
NCT00111553 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of the FilmArray® Global Fever (GF) Panel
NCT02968355 ·Status: COMPLETED
-
Clinical Study of Immunity Duration of Yellow Fever Vaccine in Military
NCT03338231 ·Status: COMPLETED
-
Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali
NCT02206451 ·Status: COMPLETED
-
Sylvatic Transmission of Zika, Dengue, and Chikungunya Viruses in Thailand and Cambodia
NCT04434846 ·Status: COMPLETED
-
Cohort of Patients Infected by an Arbovirus
NCT01099852 ·Status: UNKNOWN
-
Surveillance for Leishmaniasis Skin Lesions in Mali
NCT00344084 ·Status: COMPLETED
-
Implementation Research of New Dengue Vector Control Tools
NCT00883441 ·Status: COMPLETED ·Phase: NA
-
Rickettsiae in Myanmar
NCT03847870 ·Status: COMPLETED
-
Phase I Study of Safety and Immunogenicity of AMA1-C1Alhydrogel + CPG 7909 Vaccine for Malaria
NCT00414336 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of Project Wolbachia - Singapore on Dengue Incidence
NCT05505682 ·Status: COMPLETED ·Phase: NA
-
Sero-epidemiology of Priority Arboviruses in French Guiana
NCT03210363 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial Evaluating Safety and Efficacy of Resomelagon on Dengue Infection (RESOVIR-2)
NCT06917001 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
NCT02334462 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study
NCT05493059 ·Status: UNKNOWN